Re­search: Low-dose as­pirin re­duces risk of ovar­ian cancer

The Palm Beach Post - - MORE OF TODAY’S TOP NEWS - By Linda Sear­ing Spe­cial to Wash­ing­ton Post

Many peo­ple take a low-dose as­pirin daily in hopes of pre­vent­ing heart prob­lems. Now, re­searchers have found that women who reg­u­larly took a low-dose as­pirin — gen­er­ally 81 mil­ligrams — were 23 per­cent less likely to de­velop ovar­ian cancer than were women who did not take this type of as­pirin.

The find­ing, pub­lished in JAMA On­col­ogy, looked at med­i­cal data from 205,498 women, in­clud­ing their use of low-dose as­pirin, stan­dard-dose as­pirin (325 mg), ac­etaminophen and non­s­teroidal anti-in­flam­ma­tory drugs (NSAIDs) that do not con­tain as­pirin, such as ibupro­fen and naproxen.

In more than two decades, 1,054 of the women de­vel­oped ovar­ian cancer. Although those tak­ing low-dose as­pirin had a lower cancer risk, it ap­peared there was no ben­e­fi­cial link be­tween ovar­ian cancer de­vel­op­ment and tak­ing ei­ther stan­dard-dose as­pirin or ac­etaminophen.

In fact, the re­searchers wrote that their “re­sults sug­gest that heavy use of (NSAIDs) may be as­so­ci­ated with an in­creased risk” for ovar­ian cancer.

Although not that com­mon, ovar­ian cancer is the dead­li­est type of gyne­co­log­i­cal cancer. Women usu­ally have no symp­toms when the dis­ease is in its early stage, so it is of­ten not de­tected until the cancer is ad­vanced and has spread, mak­ing it much harder to treat.

Tak­ing low-dose as­pirin reg­u­larly, how­ever, is not right for ev­ery­one. It can in­crease your risk for bleed­ing and also lead to stom­ach ul­cers. Talk with your doc­tor be­fore start­ing a daily as­pirin reg­i­men.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.